Development of novel "enzyme-based" therapeutic approach to treat #nicotine addiction, where a nicotine degrading enzyme with high catalytic activity is used to reduce its reinforcing effects. @srntorg @SRNT_Europe @o_srnt @ATS_EOPH @LifeNoble @Alcyomics
Antidote Therapeutics continues to make progress!
Exciting update: We have progressed optimization of #nicotine-degrading enzyme, NicA2, for potential use in treating #nicotine addiction https://t.co/hJT4sEbmQ2. Results published in BMC Biotechnology https://t.co/IPK2lN7mwr
Optimization of a nicotine degrading enzyme for potential use in treatment of nicotine addiction. https://t.co/96Eo9FqMcH